domingo, 14 de octubre de 2018

A new era for drug pricing: the 'accountable choice' - STAT

A new era for drug pricing: the 'accountable choice' - STAT

First Opinion

A new era for drug pricing: the ‘accountable choice’

By JAMES C. ROBINSON


ADOBE
The current structure of patient cost-sharing for drugs is inefficient, inequitable, and arcane. We need a makeover built on reference pricing.

No hay comentarios: